Edison signs multi-billion dollar deal with DSP
This article was originally published in Scrip
Executive Summary
Edison Pharmaceuticals has signed a multi-billion dollar deal with Japanese pharma giant Dainippon Sumitomo Pharma (DSP) for the development of the former company's drugs targeting cellular energy metabolism. However, the deal includes only $10m in upfront payments, plus R&D funding of $40m.